{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 2
    }
  },
  "results": [
    {
      "discontinued_date": "06/30/2026",
      "update_type": "New",
      "initial_posting_date": "06/30/2026",
      "package_ndc": "0143-9378-01",
      "generic_name": "Daptomycin Injection",
      "contact_info": "609-395-8625 ext. 203",
      "related_info": "Discontinuation of the manufacture of the drug; Marketed by Hikma Pharmaceuticals USA, Inc.",
      "update_date": "06/30/2026",
      "therapeutic_category": [
        "Anti-Infective"
      ],
      "dosage_form": "Injection",
      "presentation": "Daptomycin, Injection, 500 mg/10 mL (NDC 0143-9378-01)",
      "company_name": "Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)",
      "status": "To Be Discontinued"
    }
  ]
}